AlphaFold predicted structure
SOST · Q9BQB4

Mean pLDDT
70.8/ 100
Confident
213 residues
Confidence breakdown
- Very high(≥ 90)25%
- Confident(70–90)19%
- Low(50–70)52%
- Very low(< 50)5%
Open interactive 3D viewer
AlphaFold (Jumper et al., 2021) · CC BY 4.0
sclerostin
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Fetal anomalies
BOTH monoallelic and biallelic, autosomal or pseudoautosomalOsteopetrosis
BOTH monoallelic and biallelic, autosomal or pseudoautosomalSkeletal dysplasia
BOTH monoallelic and biallelic, autosomal or pseudoautosomalOsteogenesis imperfecta
sclerosteosis 1
craniodiaphyseal dysplasia
hyperostosis corticalis generalisata
osteoporosis
sclerosteosis
postmenopausal osteoporosis
bone fracture
myocardial infarction
osteogenesis imperfecta
bone disorder
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Sclerostin
Negative regulator of bone growth that acts through inhibition of Wnt signaling and bone formation
SOST · Q9BQB4

Mean pLDDT
70.8/ 100
Confident
213 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0